Search Results - "Kruger, Davida"

Correlates of Insulin Injection Omission by Peyrot, Mark, Rubin, Richard R, Kruger, Davida F, Travis, Luther B

“…OBJECTIVE: The purpose of this study was to assess factors associated with patient frequency of intentionally skipping insulin injections. RESEARCH DESIGN AND…”
Get full text

Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified by Anderson, John E, Gavin, James R, Kruger, Davida F

Get more information

Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study by Shah, Viral N, DuBose, Stephanie N, Li, Zoey, Beck, Roy W, Peters, Anne L, Weinstock, Ruth S, Kruger, Davida, Tansey, Michael, Sparling, David, Woerner, Stephanie, Vendrame, Francesco, Bergenstal, Richard, Tamborlane, William V, Watson, Sara E, Sherr, Jennifer

“…Abstract Context Use of continuous glucose monitoring (CGM) is increasing for insulin-requiring patients with diabetes. Although data on glycemic profiles of…”
Get full text

Continuous Glucose Monitoring (CGM) Is a Tool, Not a Reward: Unjustified Insurance Coverage Criteria Limit Access to CGM by Kruger, Davida F, Anderson, John E

“…Recent studies have demonstrated the clinical utility of continuous glucose monitoring (CGM) use in type 2 diabetes (T2D) patients who are treated with…”
Get more information

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes by Aleppo, Grazia, Ruedy, Katrina J, Riddlesworth, Tonya D, Kruger, Davida F, Peters, Anne L, Hirsch, Irl, Bergenstal, Richard M, Toschi, Elena, Ahmann, Andrew J, Shah, Viral N, Rickels, Michael R, Bode, Bruce W, Philis-Tsimikas, Athena, Pop-Busui, Rodica, Rodriguez, Henry, Eyth, Emily, Bhargava, Anuj, Kollman, Craig, Beck, Roy W

“…To determine whether the use of continuous glucose monitoring (CGM) without confirmatory blood glucose monitoring (BGM) measurements is as safe and effective…”
Get full text

Preparing for the NASH Epidemic: A Call to Action by Kanwal, Fasiha, Shubrook, Jay H., Younossi, Zobair, Natarajan, Yamini, Bugianesi, Elisabetta, Rinella, Mary E., Harrison, Stephen A., Mantzoros, Christos, Pfotenhauer, Kim, Klein, Samuel, Eckel, Robert H., Kruger, Davida, El-Serag, Hashem, Cusi, Kenneth

“…Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are common conditions with a rising burden. Yet there are significant…”
Get full text

Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels by Bergenstal, Richard M, Gal, Robin L, Connor, Crystal G, Gubitosi-Klug, Rose, Kruger, Davida, Olson, Beth A, Willi, Steven M, Aleppo, Grazia, Weinstock, Ruth S, Wood, Jamie, Rickels, Michael, DiMeglio, Linda A, Bethin, Kathleen E, Marcovina, Santica, Tassopoulos, Andreana, Lee, Sooji, Massaro, Elaine, Bzdick, Suzan, Ichihara, Brian, Markmann, Eileen, McGuigan, Paul, Woerner, Stephanie, Ecker, Michelle, Beck, Roy W

“…Debate exists as to whether the higher hemoglobin A1c (HbA1c) levels observed in black persons than in white persons are due to worse glycemic control or…”
Get full text

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial by Bergenstal, Richard M, Johnson, Mary, Passi, Rebecca, Bhargava, Anuj, Young, Natalie, Kruger, Davida F, Bashan, Eran, Bisgaier, Stanley G, Isaman, Deanna J Marriott, Hodish, Israel

“…Insulin therapy is most effective if dosage titrations are done regularly and frequently, which is seldom practical for most clinicians, resulting in an…”
Get full text

Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review by Kruger, Davida F, Isaacs, Diana, Hughes, Lucille, Miller, Eden, Bailey, Timothy S

“…Use of innovative technologies such as continuous glucose monitoring (CGM) and insulin delivery systems have been shown to be safe and effective in helping…”
Get full text

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP) by Bergenstal, Richard M, Ahmann, Andrew J, Bailey, Timothy, Beck, Roy W, Bissen, Joan, Buckingham, Bruce, Deeb, Larry, Dolin, Robert H, Garg, Satish K, Goland, Robin, Hirsch, Irl B, Klonoff, David C, Kruger, Davida F, Matfin, Glenn, Mazze, Roger S, Olson, Beth A, Parkin, Christopher, Peters, Anne, Powers, Margaret A, Rodriguez, Henry, Southerland, Phil, Strock, Ellie S, Tamborlane, William, Wesley, David M

“…Abstract Underutilization of glucose data and lack of easy and standardized glucose data collection, analysis, visualization, and guided clinical decision…”
Get more information

Patient Perceptions of Satisfaction and Quality of Life Regarding Use of a Novel Insulin Delivery Device by Isaacs, Diana, Kruger, Davida F, Shoger, Erik, Chawla, Hiten

“…Advances in insulin delivery technologies have led to the development of tubeless "patch" systems; however, these devices still involve a level of complexity…”
Get full text

Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations by Forlenza, Gregory P, Carlson, Anders L, Galindo, Rodolfo J, Kruger, Davida F, Levy, Carol J, McGill, Janet B, Umpierrez, Guillermo, Aleppo, Grazia

“…The Tandem Control-IQ (CIQ) system has demonstrated significant glycemic improvements in large randomized controlled and real-world trials. Use of this system…”
Get more information

What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring by Galindo, Rodolfo J, Parkin, Christopher G, Aleppo, Grazia, Carlson, Anders L, Kruger, Davida F, Levy, Carol J, Umpierrez, Guillermo E, McGill, Janet B

“…Numerous studies have demonstrated the clinical value of continuous glucose monitoring (CGM) in type 1 diabetes and type 2 diabetes populations. However, the…”
Get more information

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking by Aleppo, Grazia, Hirsch, Irl B, Parkin, Christopher G, McGill, Janet, Galindo, Rodolfo, Kruger, Davida F, Levy, Carol J, Forlenza, Gregory P, Umpierrez, Guillermo E, Grunberger, George, Bergenstal, Richard M

“…Numerous studies have demonstrated the clinical benefits of continuous glucose monitoring (CGM) in individuals with type 1 diabetes (T1D) and type 2 diabetes…”
Get more information

Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment by Kruger, Davida F, LaRue, Susan, Estepa, Phil

“…Injectable treatments, such as glucagon-like peptide-1 receptor agonists and insulin, are options for the pharmacologic treatment of type 2 diabetes. Numerous…”
Get full text

71-LB: Meta-analysis of Two Real-World Chart Review Studies to Determine the Effectiveness of FreeStyle Libre Flash Glucose Monitoring System on HbA1c in Adults with Type 2 Diabetes Managed with Basal Insulin by CARLSON, ANDERS L., DANIEL, TIMOTHY D., DESANTIS, ANDREA, JABBOUR, SERGE, KARSLIOGLU-FRENCH, ESRA, KRUGER, DAVIDA F., MILLER, EDEN, OZER, KEREM, ELLIOTT, TOM

“…Two retrospective chart review studies evaluated the effectiveness of the FreeStyle Libre® Flash Glucose Monitoring System on HbA1c when used by adults with…”
Get full text

64-LB: Glucose Control after Initiation of Flash Glucose Monitoring in Type 2 Diabetes Managed with Basal Insulin: A Retrospective Real-World Chart Review Study from the U.S by CARLSON, ANDERS L., DANIEL, TIMOTHY D., DESANTIS, ANDREA, JABBOUR, SERGE, KARSLIOGLU-FRENCH, ESRA, KRUGER, DAVIDA F., MILLER, EDEN, OZER, KEREM

“…This retrospective, real-world, chart review study determined the effectiveness of the FreeStyle Libre® Flash Glucose Monitoring System on HbA1c when used by…”
Get full text

A Toast to Our History by Kruger, Davida F

“…: This article is adapted from the address Ms. Kruger delivered as the recipient of the American Diabetes Association's Outstanding Educator in Diabetes Award…”
Get full text

149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes by GAL, ROBIN L., RAGHINARU, DAN, ALEPPO, GRAZIA, OLSON, BETH A., KRUGER, DAVIDA F., BERGENSTAL, RICHARD M., WEINSTOCK, RUTH S., BRADSHAW, AMY, MCARTHUR, TERESA S., OSER, SEAN, OSER, TAMARA, HOOD, KOREY K., CUSHMAN, TERRA L., JOHNSON, MARY L., KOLLMAN, CRAIG, BECK, ROY

“…The impact of a telemedicine model for a virtual diabetes clinic was assessed 6 months following completion of a 6-month intervention of education and support…”
Get full text

263-OR: Older Adults Benefit from Virtual Support for CGM Use but Require Longer Visits by WEINSTOCK, RUTH S., THOMPSON, ZACHARY, BERGENSTAL, RICHARD M., CUSHMAN, TERRA L., GAL, ROBIN L., KOLLMAN, CRAIG, KRUGER, DAVIDA F., HOOD, KOREY K., JOHNSON, MARY L., MCARTHUR, TERESA S., OLSON, BETH A., OSER, SEAN, OSER, TAMARA, RAGHINARU, DAN, BECK, ROY, ALEPPO, GRAZIA

“…The Virtual Diabetes Specialty Clinic (VDiSC) provided type 1 (T1D) and type 2 diabetes (T2D) adults taking insulin virtual care with remote CGM training and…”
Get full text